We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Non‑Hodgkin's lymphomas of the lacrimal sac: Current insights and future directions (Review).
- Authors
Athanasopoulos, Michail; Nomikos, Georgios; Samara, Pinelopi; Mastronikolis, Stylianos; Tsilivigkos, Christos; Mastronikolis, Nicholas S.
- Abstract
Non-Hodgkin's lymphoma (NHL) of the lacrimal sac is a rare, yet clinically significant entity within the spectrum of ocular malignancies. While primary lacrimal sac lymphoma is uncommon, it poses unique diagnostic and therapeutic challenges due to its anatomical location and potential for aggressive behavior. Despite advancements being made in the current understanding and treatment of NHL, research that specifically addresses the involvement of the lacrimal sac is currently lacking. Thus, the present review aimed to provide insight into the epidemiology, clinical presentation, diagnostic modalities, histopathological features, treatment strategies and prognosis of lacrimal sac NHL. Through a methodical analysis of previous literature, the present review highlights the diverse spectrum of NHL subtypes that affect the lacrimal sac, including diffuse large B-cell lymphoma, extranodal marginal zone lymphoma, mantle cell lymphoma and follicular lymphoma. Moreover, the present review discusses the role of advanced imaging techniques in accurate staging and treatment planning, including computed tomography (CT), magnetic resonance imaging and positron emission tomography-CT. The present review also discusses evolving treatment approaches, such as surgical intervention, chemotherapy, radiotherapy, immunotherapy, combinations of the aforementioned treatments and targeted therapy. In addition, the present review highlights the significance of multidisciplinary collaboration in attaining optimal outcomes for individuals with lacrimal sac NHL. The present review aimed to provide a basis for 'further investigations into novel treatment modalities and prognostic markers that may aid in guiding personalized management strategies, ultimately improving outcomes for patients with NHL.
- Subjects
RISK assessment; NON-Hodgkin's lymphoma; RADIOTHERAPY; DIFFERENTIAL diagnosis; OCULAR tumors; IMMUNOTHERAPY; EARLY detection of cancer; COMPUTED tomography; LACRIMAL apparatus diseases; DISEASE prevalence; MAGNETIC resonance imaging; TUMOR markers; CELLULAR signal transduction; CANCER chemotherapy; IMMUNOHISTOCHEMISTRY; GENE expression profiling; MOLECULAR diagnosis; DISEASE risk factors; SYMPTOMS
- Publication
Medicine International (2754-3242), 2024, Vol 4, Issue 4, pN.PAG
- ISSN
2754-3242
- Publication type
Article
- DOI
10.3892/mi.2024.167